Therefore, we analyzed in vitro and in situ release of carboxypeptidase E (CPE) and secretogranin III (SgIII), two established DCVs markers which are aberrantly accumulated in neurons and astrocytes in the cerebral cortex of AD patients and amyloid-forming transgenic mice (Plá et al., 2013). Here, CPE is linked to Alzheimer disease.